TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biognos AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
98
|
0
|
121 |
| Financial expenses |
0
|
0
|
2 |
| Earnings before taxes |
-886
|
-1,234
|
-1,217 |
| EBITDA |
-886
|
-1,227
|
-1,198 |
| Total assets |
2,696
|
610
|
552 |
| Current assets |
169
|
610
|
546 |
| Current liabilities |
328
|
422
|
362 |
| Equity capital |
1,366
|
186
|
190 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
30.5%
|
34.4% |
| Turnover per employee |
98
|
0
|
121 |
| Profit as a percentage of turnover | -904.1% | -1005.8% | |
| Return on assets (ROA) |
-32.9%
|
-202.3%
|
-220.1% |
| Current ratio |
51.5%
|
144.5%
|
150.8% |
| Return on equity (ROE) |
-64.9%
|
-663.4%
|
-640.5% |
| Change turnover |
98
|
-130
|
-803 |
| Change turnover % |
-100%
|
-87% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.